ARCHIVES

Phase II Study of Veliparib Improves PFS by 35 Percent

This article is from The Cancer Letter archive.

Vol. 37 No. 10 | October 31, 2014

Download PDF Visit The Full Archive

Related Articles

Research Integrity: Collins’ Student Falsified Data, ORI Finds

August 22, 1997

Herceptin Regimen Minus Adriamycin Increases Survival With Less Toxicity

October 28, 2011

NCAB Approves New Pancreatic Cancer Project, Hears Favorable Reports On Organ site Programs

November 29, 1974

Mayo Clinic Cancer Center Wins NCI Support Grant Renewal

June 19, 2009

Frei, Freireich Share One GM Prize; Ames, Erikson Win Others

June 17, 1983

Breast Removal Reduces Risk Of Cancer In BRCA Carriers

October 26, 2001